Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (RO1 AR068275)
George M. Eisenberg Foundation for Charities
National Institutes of Health (R01 CA133049-01)
Mayo Clinic Breast Cancer Specialized Program of Research Excellence Grant (P50CA 116201)
Prospect Creek Foundation
The Regis Foundation
Received: 2 September 2019
Accepted: 3 May 2020
First Online: 19 May 2020
Ethics approval and consent to participate
: Not applicable.
: All authors agreed on submitting this work for publication.
: MPG reports personal fees from Genomic Health for consulting, others from Novartis, Pfizer, Sermonix, Context Pharm, and Biotheranostics, and grants from Pfizer, Eli-Lilly, outside of the submitted work. The other authors declare that they have no competing interests.